Robert S. Svatek

The University of Texas at San Antonio Health Science Center

Also affiliated with The University of Texas at San Antonio, The University of Texas Health Science Center at Houston

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer”.

Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer

New England Journal of Medicine(2024)10.1056/nejmoa2401497

N/A

2.4DataRank · unranked

64 citations

Catherine M. Tangen, Robert S. Svatek, Siamak Daneshmand, Kamal S. Pohar, Eila C. Skinner +15 more

CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002051

N/A

0DataRank · unranked

22 citations

Yilun Deng, Deyi Zhang, Niannian Ji, Neelam Mukherjee, Karen Wheeler +11 more

A Randomized Feasibility Trial Comparing Surveillance Regimens for Patients with Low and Low-Intermediate Risk Non-Muscle Invasive Bladder Cancer

Bladder Cancer(2021)10.3233/blc-201535

N/A

0DataRank · unranked

11 citations

Emily Rios, Shane Barney, Cory M. Hugen, Joel Michalek, Yair Lotan +3 more

γδ T Cells Support Antigen-Specific αβ T cell–Mediated Antitumor Responses during BCG Treatment for Bladder Cancer

Cancer Immunology Research(2021)10.1158/2326-6066.cir-21-0285

N/A

0DataRank · unranked

19 citations

Neelam Mukherjee, Zhen‐Ju Shu, Ryan M. Reyes, Joshua J. Meeks, David J. McConkey +4 more

Tumor Intrinsic PD-L1 Promotes DNA Repair in Distinct Cancers and Suppresses PARP Inhibitor–Induced Synthetic Lethality

Cancer Research(2022)10.1158/0008-5472.can-21-2076

N/A

0DataRank · unranked

70 citations

Jacob T. Boyd, Clare Murray, Julia Saifetiarova, Bárbara de la Peña Avalos, Cody M. Rogers +15 more

KLRF1, a novel marker of CD56bright NK cells, predicts improved survival for patients with locally advanced bladder cancer

Cancer Medicine(2022)10.1002/cam4.5579

N/A

0DataRank · unranked

16 citations

Niannian Ji, Xi Tan, Chun‐Liang Chen, Onika D.V. Noel, Maria Rodriguez‐Padron +5 more

Selective delipidation of Mycobacterium bovis BCG retains antitumor efficacy against non-muscle invasive bladder cancer

Cancer Immunology Immunotherapy(2022)10.1007/s00262-022-03236-y

N/A

0DataRank · unranked

8 citations

Meijun Long, Andreu Garcia‐Vilanova, Russell Ault, Juan I. Moliva, Kizil A. Yusoof +6 more

Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer

Bladder Cancer(2023)10.3233/blc-230056

N/A

0DataRank · unranked

8 citations

Noah M. Hahn, Seth P. Lerner, Jaleh Fallah, Sundeep Agrawal, Ashish M. Kamat +33 more

Innate Lymphoid Cells in Bladder Cancer: From Mechanisms of Action to Immune Therapies

Cancer Immunology Research(2023)10.1158/2326-6066.cir-23-0414

N/A

0DataRank · unranked

6 citations

Zaineb Hassouneh, Robert S. Svatek, Neelam Mukherjee, Onika D.V. Noel

SWOG S1011: A phase III surgical trial to evaluate the benefit of a standard versus an extended lymphadenectomy performed at time of radical cystectomy for muscle invasive urothelial cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4508

N/A

0DataRank · unranked

39 citations

Catherine M. Tangen, Robert S. Svatek, Siamak Daneshmand, Kamal S. Pohar, Eila C. Skinner +15 more

Data from γδ T Cells Support Antigen-Specific αβ T cell–Mediated Antitumor Responses during BCG Treatment for Bladder Cancer

(2023)10.1158/2326-6066.c.6550607

N/A

0DataRank · unranked

0 citations

Neelam Mukherjee, Zhen‐Ju Shu, Ryan M. Reyes, Joshua J. Meeks, David J. McConkey +4 more

Tumour-intrinsic PDL1 signals regulate the Chk2 DNA damage response in cancer cells and mediate resistance to Chk1 inhibitors

Molecular Cancer(2024)10.1186/s12943-024-02147-z

N/A

0DataRank · unranked

11 citations

Anand Kornepati, Carlos Ontiveros, Yiji Liao, Bárbara de la Peña Avalos, Cody M. Rogers +25 more

Perioperative Immune Checkpoint Blockade for Muscle-Invasive and Metastatic Bladder Cancer

Journal of Cancer Immunology(2024)10.33696/cancerimmunol.6.081

N/A

0DataRank · unranked

4 citations

Karen Wheeler, Shaun Trecarten, Zaineb Hassouneh, Niannian Ji, Yi‐Fen Lee +3 more

The Laws of Attraction: Chemokines as Critical Mediators in Cancer Progression and Immunotherapy Response in Bladder Cancer

Cancers(2024)10.3390/cancers16193303

N/A

0DataRank · unranked

2 citations

M. Kim, Natalia Bowman, Manjeet K. Rao, Nu Zhang, Gang Huang +3 more

CD56 on intratumoral NK cells: orchestrating NK cell-mediated anti-tumor effects in bladder cancer

Neoplasia(2025)10.1016/j.neo.2025.101187

N/A

0DataRank · unranked

2 citations

Onika D.V. Noel, Niannian Ji, M. Kim, Natalia Bowman, Robert S. Svatek +3 more

Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy

Cancer Medicine(2021)10.1002/cam4.3739

N/A

0DataRank · unranked

47 citations

Ryan M. Reyes, Erica Osta, Suresh Kari, Harshita B. Gupta, Álvaro Padrón +10 more

A Double‐Humanized Murine Model in Bladder Cancer: A Novel Preclinical Model for Cancer Immunology Research

Cancer Medicine(2025)10.1002/cam4.71150

N/A

0DataRank · unranked

1 citations

Zaineb Hassouneh, Shaun Trecarten, Zhen-Ju Shu, Jaime Furman, Tyler J. Curiel +3 more